Skip to main content

Tarsus Pharmaceuticals, Inc 10-K for FY2025

Tarsus Pharmaceuticals, Inc. (TARS)

10-K 2026-02-23 For: 2025-12-31
View Original
Added on April 04, 2026

About this 10-K

Tarsus Pharmaceuticals, Inc filed this 10-K on February 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$451.36M
up 146.7% from $182.95M a year earlier
Net loss
$66.42M
compared with a net loss of $115.55M a year earlier
Diluted EPS
-$1.59
compared with -$3.07 a year earlier